Theralase Technologies Inc (TLTFF)

[Luckypennyman]

Toronto, Ontario – April 21, 2020, Theralase® Technologies Inc.


(“Theralase” or the “Company”)
(TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and
development of light activated Photo Dynamic Compounds (“PDC”) and associated drug
formulations has released the Company Quarterly Newsletter.
The Newsletter provides updates on the previous quarter and progress on the Phase II Non-Muscle
Invasive Bladder Cancer (“NMIBC”) Clinical Study. The Newsletter can be found on the Company’s
website www.theralase.com/invest/.